Carboxylate derivatives of tributyltin (IV) complexes as anticancer and antileishmanial agents

A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules

(2016) Antoine Daina et al.   ChemMedChem

Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts

(2016) Lisa Fish et al.   GENES & DEVELOPMENT

The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis

(2016) Pedro Paulo Carneiro et al.   PLoS One

Extraction optimization of medicinally important metabolites from Datura innoxia Mill.: an in vitro biological and phytochemical investigation

(2015) Humaira Fatima et al.   BMC Complementary and Alternative Medicine

Targeting cancer with kinase inhibitors

(2015) Stefan Gross et al.   JOURNAL OF CLINICAL INVESTIGATION

Organometallic Compounds in Cancer Therapy: Past Lessons and Future Directions

(2014) Pedro Martins et al.   Anti-Cancer Agents in Medicinal Chemistry

Synthesis, Characterization, Semiempirical and Biological Activities of Organotin(IV) Carboxylates with 4-Piperidinecarboxylic Acid

(2014) Shabbir Hussain et al.   BIOINORGANIC CHEMISTRY AND APPLICATIONS

Cisplatin in cancer therapy: Molecular mechanisms of action

(2014) Shaloam Dasari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

PEGylated silver doped zinc oxide nanoparticles as novel photosensitizers for photodynamic therapy against Leishmania

(2014) Akhtar Nadhman et al.   FREE RADICAL BIOLOGY AND MEDICINE

iLOGP: A Simple, Robust, and Efficient Description of n-Octanol/Water Partition Coefficient for Drug Design Using the GB/SA Approach

(2014) Antoine Daina et al.   Journal of Chemical Information and Modeling

SwissTargetPrediction: a web server for target prediction of bioactive small molecules

(2014) David Gfeller et al.   NUCLEIC ACIDS RESEARCH

Organotin(iv) carboxylate derivatives as a new addition to anticancer and antileishmanial agents: design, physicochemical characterization and interaction with Salmon sperm DNA

(2014) Muhammad Sirajuddin et al.   RSC Advances

Mechanisms of Hepatocyte Growth Factor Activation in Cancer Tissues

(2014) Makiko Kawaguchi et al.   Cancers

Leishmaniasis: Current status of available drugs and new potential drug targets

(2012) Nisha Singh et al.   Asian Pacific Journal of Tropical Medicine

Study of the Anticancer Properties of Tin(IV) Carboxylate Complexes on a Panel of Human Tumor Cell Lines

(2011) Lourdes Rocamora-Reverte et al.   ChemMedChem

Sodium azide as a specific quencher of singlet oxygen during chemiluminescent detection by luminol and Cypridina luciferin analogues

(2011) Martina Bancirova   LUMINESCENCE

Granzymes in cancer and immunity

(2010) S P Cullen et al.   CELL DEATH AND DIFFERENTIATION

Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac death

(2010) C. van Noord et al.   HEART

In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences

(2009) M. Vermeersch et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Leishmania majorMPK7 Protein Kinase Activity Inhibits Intracellular Growth of the Pathogenic Amastigote Stage

(2009) Miguel A. Morales et al.   EUKARYOTIC CELL

6-Br-5methylindirubin-3′oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: Exploitation of GSK-3 for treating leishmaniasis

(2009) Evangelia Xingi et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

Platinum neurotoxicity pharmacogenetics

(2009) S. R. McWhinney et al.   MOLECULAR CANCER THERAPEUTICS

Pentavalent Antimonials: New Perspectives for Old Drugs

(2009) Frédéric Frézard et al.   MOLECULES

Assessing drug-likeness – what are we missing?

(2008) Giulio Vistoli et al.   DRUG DISCOVERY TODAY